ÌÇÐÄÊÓÆµ

Thomas Peter Giordano

Giordano

Thomas Peter Giordano, M.D., M.P.H.

Section Chief of Infectious Diseases

(713) 798-8918

Email

tpg@bcm.edu

Positions

Section Chief of Infectious Diseases
ÌÇÐÄÊÓÆµ of Medicine
Houston, TX, US
Professor
Medicine
Infectious Diseases
ÌÇÐÄÊÓÆµ of Medicine
Houston, Texas, United States
Director
Texas Developmental Center for AIDS Research
MD Anderson Foundation Chair
ÌÇÐÄÊÓÆµ of Medicine
Staff Physician
Infectious Diseases
Harris Health System

Education

BS from John Carroll University
05/1988 - Cleveland, OH, United States
Biology
BA from John Carroll University
05/1988 - Cleveland, OH, United States
Humanities
MA from Cornell University
08/1992 - Ithaca, NY, United States
History of Art
MD from Johns Hopkins University School Of Medicine
05/1996 - Baltimore, MD, United States
Medicine
Residency at Hospital Of The University Of Pennsylvania
06/1999 - Philadelphia, PA, United States
Internal Medicine
Fellowship at ÌÇÐÄÊÓÆµ Of Medicine
05/2002 - Houston, TX, United States
Infectious Diseases
MPH from University Of Texas Health Science Center School Of Public Health
06/2004 - Houston, TX, United States
Disease Control

Certifications

Board Certified in Internal Medicine
(10/01/1999 - 12/01/2009)
American Board of Internal Medicine
Board Certified in Infectious Diseases
(12/01/2002 - 12/01/2022)
American Board of Internal Medicine

Professional Interests

  • HIV testing, adherence to antiretroviral therapy, and retention in HIV care

Professional Statement

Dr. Giordano is chief of the Section of Infectious Diseases, professor in the Department of Medicine, and MD Anderson Foundation Chair at ÌÇÐÄÊÓÆµ of Medicine. He is also Director of the Texas Developmental Center for AIDS Research and was the Medical Director of the Thomas Street Health Center, one of the largest HIV clinics in the United States, from 2004 to 2021. His research focuses on HIV testing, adherence to antiretroviral therapy, and retention in HIV care.

Dr. Giordano has a strong track record of scientific achievements. His research has focused on improving care delivery and adherence to care for people with HIV infection in the US. His work has been recognized nationally and he is regarded as an authority in adherence and retention in HIV care research. He has been the recipient of highly competitive research grants and contracts, including 15 grants as the principal investigator, and has published more than 180 peer-review manuscripts.

Locally and nationally, he has participated in several service and leadership roles. Locally, he served as Medical Director of HIV Services for Harris Health from 2004 to 2021, and helped raise the national reputation of Harris Health’s flagship HIV clinic, Thomas Street Health Center. Nationally, Dr. Giordano completed a term as a standing member of an NIH Study Section and has served as grant reviewer for VA and other entities. He is a former member of the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, which authors HIV treatment guidelines used nationally and internationally. He has served as Track Chair for the Continuum of Care Track at the International Conference on HIV Treatment and Prevention Adherence, and completed a term on the FDA Scientific Advisory Panel that reviewed antiviral drugs.

Websites

Selected Publications

  • Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. " " HIV Clin Trials. ; 5 (2) : 74-9.
    Pubmed PMID: .
  • Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB. " " Arch. Intern. Med.. 2004 Nov 22; 164 (21) : 2349-54.
    Pubmed PMID: .
  • Giordano TP, White AC, Sajja P, Graviss EA, Arduino RC, Adu-Oppong A, Lahart CJ, Visnegarwala F. " " J. Acquir. Immune Defic. Syndr.. 2003 Apr 1; 32 (4) : 399-405.
    Pubmed PMID: .
  • Giordano TP, Visnegarwala F, White AC, Troisi CL, Frankowski RF, Hartman CM, Grimes RM. " " AIDS Care. 2005 Aug ; 17 (6) : 773-83.
    Pubmed PMID: .

Memberships

Infectious Diseases Society of America
Member (01/1999)
HIV Medicine Association
Member (01/2001)
International AIDS Society
Member (01/2002)
US FDA Antiviral Drug Advisory Committee
Member (01/2011 - 10/2014)
International Association of Physicians in AIDS Care
Member (01/2011)
NIH Review Panel BSCH, Social and Behavioral Consequences of HIV/AIDS
Member (01/2012 - 01/2018)
Infectious Diseases Society of America
Fellow (01/2012)
The Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents
Member (01/2014 - 09/2023)
Center for AIDS Research, ÌÇÐÄÊÓÆµ of Medicine
Member (04/2021)

Funding

Test of an intervention to improve retention in HIV care after hospitalization
#1 R01 MH085527-01A1
(09/15/2009 - 07/31/2015)
Grant funding from National Institutes of Health, NIMH
The goal of this project is to conduct a randomized, controlled, trial of a patient-mentor based intervention to improve retention in HIV care among patients hospitalized with HIV infection. Role: Principal Investigator
Comprehensive Prevention with Positives Intervention at HIV Clinics
#200-2011-41982
(09/28/2011 - 09/27/2016)
Grant funding from U. S. Centers for Disease Control and Prevention and National Institutes of Mental Health
The goal of this project is to test the effectiveness of an intervention to prevent HIV transmission by decreasing high-risk behavior, improving adherence to care and antiretroviral therapy, and increasing the proportion of patients with viral suppression. This multi-component intervention will include provider training, provider feedback, and both computer and personally delivered behavioral interventions for patients. Role: Principal Investigator
Texas Developmental Center for AIDS Research
#P30AI161943
(04/23/2021 - 03/31/2026)
Grant funding from National Institutes of Health
The Texas Developmental-Center for AIDS Research (Texas D-CFAR) is a one-of-a-kind Center in Texas, a region of the United States that is heavily impacted by the HIV epidemic. The center conducts cutting-edge HIV research, catalyzes research collaborations across Texas, trains the next generation of top HIV researchers and clinicians, and engages our community to implement solutions that optimize HIV health and HIV prevention. The Texas D-CFAR supports the overall mission of the national Center for AIDS Research (CFAR) program to end the HIV epidemic in the United States.
Targeting HIV Retention and Improved Viral load through Engagement ('THRIVE')
#R34MH122294
(07/01/2020 - 06/30/2023)
Grant funding from National Institutes of Mental Health
The goal of this project is to develop and preliminarily test an intervention based on Acceptance and Commitment Therapy for people with HIV who are not in regular outpatient care for HIV and who are hospitalized at Ben Taub Hospital in Houston, Texas.
VA Video Connect to Improve Access to Multi-disciplinary Specialty Care
#I01-HX002645
(01/01/2020 - 12/31/2024)
Grant funding from Department of Veterans Affairs, Health Services Research and Development
This project will test the effectiveness of VA Video Connect telehealth services in Veterans with HIV and study the implementation of these telehealth services in other VA facilities.
Retaining HIV positive patients in medical care: Test of intervention strategy for HIV clinics
#200-2007-23685
(09/28/2007 - 06/30/2013)
Grant funding from Centers for Disease Control and Prevention and Health Resources and Services Administration
The major goal of this project is to develop and evaluate in a multi-site randomized clinical trial a multi-component intervention to retain HIV positive patients in medical care, including provider training, patient education, patient behavioral interventions, and appointment reminders. Role: Principal Investigator
Project Hi-5, Building a Medical Home for Multiply Diagnosed HIV-positive Homeless Populations – Houston Demonstration Site
#1 H97HA24959
(09/01/2012 - 08/31/2017)
Grant funding from HRSA-HAB
To build a medical home for homeless persons with HIV infection and either serious mental illness or substance use problems in Houston, and contribute to a national demonstration project focusing on that goal. Role: Principal Investigator
Wastewater Sampling: A New Tool to Accelerate Ending the HIV Epidemic
#1R01DA059394-01A1
$3,875,000.00   (09/15/2023 - 07/31/2028)
NIDA, NIH
The specifics aims of this project are: 1) To develop a sensitive, reproducible, and streamlined wastewater HIV detection pipeline; 2) To develop epidemiologic models incorporating data from wastewater sampling as a novel and informative parameter along with routine surveillance data on HIV diagnoses and population data; 3) To characterize and incorporate stakeholder preferences, priorities, and recommendations for engaging key community stakeholders in the HIV wastewater sampling program with consideration to the ethical, legal, social, and cultural contexts of individuals living in target neighborhoods; 4) To determine if delivering proven public health interventions to neighborhoods as directed by wastewater data can reduce the wastewater viral load and increase HIV diagnoses in those neighborhoods.

to edit your profile